darunavir has been researched along with AIDS Nephropathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bommana, GM; D'Agati, V; Gao, X; Habib, Z; Karttunen, H; Rosales, A; Ross, MJ; Tandoh, B; Yi, Z; Zhang, W | 1 |
1 other study(ies) available for darunavir and AIDS Nephropathy
| Article | Year |
|---|---|
The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms.
Topics: AIDS-Associated Nephropathy; Animals; Cell Line; Darunavir; HIV Protease Inhibitors; HIV-1; Humans; Kidney; MAP Kinase Signaling System; Mice; Mice, Transgenic; Zidovudine | 2019 |